Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Research article

What does it cost to redispense unused medications in the pharmacy? A micro-costing study

Authors: Charlotte L. Bekker, Helga Gardarsdottir, Antoine C. G. Egberts, Hendrik A. Molenaar, Marcel L. Bouvy, Bart J. F. van den Bemt, Anke M. Hövels

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Redispensing unused medications that have been returned to outpatient pharmacies by patients may reduce waste and healthcare costs. However, little is known regarding the extra costs associated with this process, nor the price level of medications for which this is economically beneficial. The objective of this study was to assess costs associated with redispensing unused medications in the pharmacy and the price level at which redispensing becomes cost-beneficial.

Methods

A micro-costing study was conducted in four Dutch outpatient pharmacies for medications requiring room-temperature storage and requiring refrigeration. First, the pharmacy’s necessary additional process steps and resources for redispensing were identified. Second, time required for each process step was simulated. Third, required resources were quantified by calculating labour, purchasing and overhead costs. Lastly, a model with different scenarios was constructed to calculate the price of a medication package at which redispensing becomes cost-beneficial.

Results

Three main additional process steps for redispensing were identified: (1) pack medications with product quality indicators before dispensing, (2) assess quality of medications returned to the pharmacy (temperature storage, package integrity, expiry date) and (3a) restock medications fulfilling quality criteria or (3b) dispose of medications not fulfilling criteria. Total time required for all steps up to restock one medication package was on average 5.3 (SD ±0.3) and 6.8 (SD ±0.3) minutes for medications stored at room-temperature and under refrigeration, respectively, and associated costs were €5.54 and €7.61. Similar outcomes were found if a medication package would ultimately be disposed of. The price level primarily depended upon the proportion of dispensed packages returned unused to the pharmacy and fulfilling the quality criteria: if 5% is returned, of which 60% fulfils quality criteria, the price level was €101 per package for medications requiring room-temperature storage and €215 per package for those requiring refrigeration. However, if 10% is returned, of which 60% fulfils the quality criteria, the price level decreases to €53 and €109, respectively (arbitrary proportions).

Conclusions

Redispensing unused medications in the pharmacy is at least cost-beneficial if applied to expensive medications.
Literature
2.
go back to reference Trueman P, Lowson K, Blighe A, Meszaros A, Wright D, Glanville J. Evaluation of the scale , causes and costs of waste medicines. London: YHEC/School of Pharmacy, University of London; 2010. ISBN 978 090 293 620 1. Trueman P, Lowson K, Blighe A, Meszaros A, Wright D, Glanville J. Evaluation of the scale , causes and costs of waste medicines. London: YHEC/School of Pharmacy, University of London; 2010. ISBN 978 090 293 620 1.
3.
go back to reference Reitsma M, Brabers A, Korevaar J, De JJ, van DM, van DL. One third of the medicine users has medicines left unused [Dutch]. Utrecht: Nivel; 2013. Reitsma M, Brabers A, Korevaar J, De JJ, van DM, van DL. One third of the medicine users has medicines left unused [Dutch]. Utrecht: Nivel; 2013.
4.
go back to reference Kusturica M, Tomas A, Sabo A. Diposal of unused drugs: knowledge and behaviour among people around the world. Rev Environ Contam Toxicol. 2017;240:71–104. Kusturica M, Tomas A, Sabo A. Diposal of unused drugs: knowledge and behaviour among people around the world. Rev Environ Contam Toxicol. 2017;240:71–104.
6.
go back to reference Mackridge AJ, Marriott JF. Returned medicines: waste or a wasted opportunity? J Public Health. 2007;29:258–62.CrossRef Mackridge AJ, Marriott JF. Returned medicines: waste or a wasted opportunity? J Public Health. 2007;29:258–62.CrossRef
7.
go back to reference Bekker CL, Bemt BJF Van Den, Egberts ACG, Bouvy ML, Gardarsdottir H. Patient and medication factors associated with preventable medication waste and possibilities for redispensing. Int J Clin Pharm. 2018;40(3):704–711.CrossRef Bekker CL, Bemt BJF Van Den, Egberts ACG, Bouvy ML, Gardarsdottir H. Patient and medication factors associated with preventable medication waste and possibilities for redispensing. Int J Clin Pharm. 2018;40(3):704–711.CrossRef
9.
go back to reference Tchen J, Vaillancourt R, Pouliot A. Wasted medications, wasted resource. Can Pharm J. 2013;146:181–2.CrossRef Tchen J, Vaillancourt R, Pouliot A. Wasted medications, wasted resource. Can Pharm J. 2013;146:181–2.CrossRef
10.
go back to reference Bekker CL, Gardarsdottir H, Egberts TCG, Bouvy ML, van den Bemt BJF. Redispensing of medicines unused by patients: a qualitative study among stakeholders. Int J Clin Pharm. 2017;39:196–204.CrossRef Bekker CL, Gardarsdottir H, Egberts TCG, Bouvy ML, van den Bemt BJF. Redispensing of medicines unused by patients: a qualitative study among stakeholders. Int J Clin Pharm. 2017;39:196–204.CrossRef
12.
go back to reference WHO. Guidelines for medicine donations revised 2010. Geneva; 2011. WHO. Guidelines for medicine donations revised 2010. Geneva; 2011.
13.
go back to reference Mcrae D, Allman M, James D. The redistribution of medicines: could it become a reality. Int J Pharm Pract. 2016;24:411–8.CrossRef Mcrae D, Allman M, James D. The redistribution of medicines: could it become a reality. Int J Pharm Pract. 2016;24:411–8.CrossRef
14.
go back to reference Drummond MF, Sculper MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care Programmes. London: Oxford University Press; 2015. Drummond MF, Sculper MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care Programmes. London: Oxford University Press; 2015.
15.
go back to reference Guideline for economic evaluations in healthcare [Dutch]. Diemen: Zorginstituut Nederland; 2015. Guideline for economic evaluations in healthcare [Dutch]. Diemen: Zorginstituut Nederland; 2015.
16.
go back to reference Vlieland ND, Gardarsdottir H, Bouvy ML, Egberts TCG. Bemt BJF Van Den. The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range. Rheumatology. 2016;55:704–9.CrossRef Vlieland ND, Gardarsdottir H, Bouvy ML, Egberts TCG. Bemt BJF Van Den. The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range. Rheumatology. 2016;55:704–9.CrossRef
17.
go back to reference Vlieland ND, Van Den BBJF, van R-ND, Bouvy ML, Egberts ACG, Gardarsdottir H. Actual versus recommended storage temperatures of oral oncolytic drugs at patients’ homes. J Oncol Pharm Pract. 2016;25(2):382–389. Vlieland ND, Van Den BBJF, van R-ND, Bouvy ML, Egberts ACG, Gardarsdottir H. Actual versus recommended storage temperatures of oral oncolytic drugs at patients’ homes. J Oncol Pharm Pract. 2016;25(2):382–389.
18.
go back to reference Dutch Society for Pharmacists. CAO Pharmacies [Dutch] 2015. Dutch Society for Pharmacists. CAO Pharmacies [Dutch] 2015.
19.
go back to reference Costing guide: methods of cost research and reference pricing for economic evaluations in healthcare [Dutch]. Rotterdam: Institute for Medical Technology Assessment, Erasmus University Rotterdam; 2015. Costing guide: methods of cost research and reference pricing for economic evaluations in healthcare [Dutch]. Rotterdam: Institute for Medical Technology Assessment, Erasmus University Rotterdam; 2015.
21.
go back to reference Toh MR, Chew L. Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage. Palliat Med. 2017;31:35–41.CrossRef Toh MR, Chew L. Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage. Palliat Med. 2017;31:35–41.CrossRef
22.
go back to reference Lenzer J. US could recycle 10 million unused prescription drugs a year, report says. BMJ. 2014;349:g7677.CrossRef Lenzer J. US could recycle 10 million unused prescription drugs a year, report says. BMJ. 2014;349:g7677.CrossRef
23.
go back to reference Langley C, Marriott J, Mackridge A, Daniszewski R. An analysis of returned medicines in primary care. Pharm World Sci. 2005;27:296–9.CrossRef Langley C, Marriott J, Mackridge A, Daniszewski R. An analysis of returned medicines in primary care. Pharm World Sci. 2005;27:296–9.CrossRef
24.
go back to reference Bekker CL, Melis EJ, Egberts ACG, Bouvy ML, Gardarsdottir H, Van Den Bemt BJF. Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy. Res Social Adm Pharm. 2019;15(1):100–105.CrossRef Bekker CL, Melis EJ, Egberts ACG, Bouvy ML, Gardarsdottir H, Van Den Bemt BJF. Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy. Res Social Adm Pharm. 2019;15(1):100–105.CrossRef
25.
go back to reference Glanville M, Brady R, Miller S. Operation donate: defining the value of redispensing medications donated by individuals. J Am Pharm Assoc. 2014;54:542–7.CrossRef Glanville M, Brady R, Miller S. Operation donate: defining the value of redispensing medications donated by individuals. J Am Pharm Assoc. 2014;54:542–7.CrossRef
26.
go back to reference Alhamad H, Patel N, Donyai P. How do people conceptualise the reuse of medicines? An interview study. Int J Pharm Pract. 2018;26:231–41.CrossRef Alhamad H, Patel N, Donyai P. How do people conceptualise the reuse of medicines? An interview study. Int J Pharm Pract. 2018;26:231–41.CrossRef
27.
go back to reference Hendrick A, Baqir W, Barrett S, Campbell D. Prescribing Mrs Smith’s medication to Mr Jones: the views of patients and professionals on the reuse of returned medicines. Pharm Manag. 2013;29:25–6. Hendrick A, Baqir W, Barrett S, Campbell D. Prescribing Mrs Smith’s medication to Mr Jones: the views of patients and professionals on the reuse of returned medicines. Pharm Manag. 2013;29:25–6.
28.
go back to reference Dicomidis J, Kirby A. Reuse of medicines: looking beyond the waste blame game. Prescriber. 2012;23:13–7.CrossRef Dicomidis J, Kirby A. Reuse of medicines: looking beyond the waste blame game. Prescriber. 2012;23:13–7.CrossRef
29.
go back to reference Koster ES, Blom L, Philbert D, Rump W, Bouvy ML. The Utrecht pharmacy practice network for education and research: a network of community and hospital pharmacies in the Netherlands. Int J Clin Pharm. 2014;36:669–74.CrossRef Koster ES, Blom L, Philbert D, Rump W, Bouvy ML. The Utrecht pharmacy practice network for education and research: a network of community and hospital pharmacies in the Netherlands. Int J Clin Pharm. 2014;36:669–74.CrossRef
Metadata
Title
What does it cost to redispense unused medications in the pharmacy? A micro-costing study
Authors
Charlotte L. Bekker
Helga Gardarsdottir
Antoine C. G. Egberts
Hendrik A. Molenaar
Marcel L. Bouvy
Bart J. F. van den Bemt
Anke M. Hövels
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4065-6

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue